Prostanoid receptors in GtoPdb v.2021.2
Lucie H. Clapp(The London College), Chengcan Yao(University of Edinburgh), Shuh Narumiya(Kyoto University), Yukihiko Sugimoto(Kumamoto University), David F. Woodward(Imperial College London), Robert L. Jones(University of Strathclyde), Ákos Heinemann(Medical University of Graz), Mark A. Giembycz(University of Calgary), Xavier Norel(Inserm)
Cited by 2
Related Papers
Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells
|British Journal of Pharmacology|1997|512
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Role of Prostaglandin E Receptor Subtypes (EP1, EP2, EP3, and EP4) in Bone Resorption: An Analysis Using Specific Agonists for the Respective EPs
|Endocrinology|2000|391
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Terlipressin for norepinephrine-resistant septic shock
|The Lancet|2002|259